A new experimental drug, Nerandomilast, has shown potential in reducing lung inflammation and fibrosis in preclinical models of Idiopathic Inflammatory Myopathy–Associated Interstitial Lung Disease ...

Kidney disease often develops silently, with many people unaware of the condition until it becomes severe. According to nephrologist Topoti Mukherjee, certain changes in the legs — including swelling, ...

Reduced progression of myocardial fibrosis measured by LGE on cardiac MRI (p=0.022)Significant improvement in LVEF versus placebo in patients with baseline cardiomyopathy (p=0.017)Global Statistical ...

You know too much salt isn’t the best thing for you, but how exactly does it affect your heart? Here’s what science says.

Many kidney diseases can be avoided or their course can be changed with the help of doctors who recognise them at the very first stages.

A diabetologist attributes his 37 kg weight loss to structured exercise and metabolic correction, emphasising insulin control and sustainable habits. | Health ...

Dr. Matthew Galsky spoke with CURE about the KEYNOTE-B15 trial results and their potential impact on muscle-invasive bladder cancer care. At the 2026 ASCO Genitourinary Cancers Symposium, the ...

Subtle onset or changes in symptoms of ATTR-CM can indicate worsening heart failure. Learn how to track symptoms and when to seek medical attention.

Chronic inflammatory demyelinating polyradiculoneuropathy is a rare autoimmune-related condition that affects nerve signaling ...

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology company developing transformative therapies for the treatment of cancer and rare ...

Tick-borne diseases are on the rise in the northeastern US, with many ticks carrying more than one pathogen. So reports a ...

Apitegromab improved motor function in SMA patients in a Phase 3 trial analysis, with stronger benefits seen in those treated earlier.